Industry sourcing decision
Medical device work can include early fixtures, instrument housings, motion components, fluid-handling parts and production-intent assemblies, but an industry label does not define the manufacturing or regulatory route. MakeNexa reviews the part function, device context, released files and evidence needs, then routes the RFQ through a global supplier network. Supplier fit, material, tolerance, cleanliness, documentation, inspection and compliance are confirmed for each project.
Application context
Begin with the component's role and the consequence of failure. State whether it is a development fixture, equipment enclosure, non-patient-contact mechanism, fluid-path component, reusable instrument part or another defined category. Identify contact media, service environment, cleaning exposure, load, motion, sealing interfaces and whether the component is evaluated alone or inside a larger device. These facts influence material, process, supplier qualification and evidence; the words medical device do not supply them.
Next, define the controlled manufacturing package. Provide the authoritative model and drawing, revision, material and condition, critical features, finish or cleanliness notes, quantity and build stage. List required material records, dimensional reports, lot separation, change notification, packaging or supplier quality-system expectations explicitly. MakeNexa can review and route those requirements, but generated imagery, a supplier's general profile or completion of a component cannot establish device safety, regulatory clearance or suitability for use.
Typical program needs
The route is useful when the component needs more context than a process-only RFQ can communicate.
Benchtop fixtures, test stands, handling nests and engineering aids can require fast revision control, repeatable interfaces and safe material handling without being part of the marketed device. Mark their use clearly so production-device requirements are neither omitted nor applied without reason.
Machined, molded or fabricated housings, covers, brackets, stages and drive components may depend on alignment, access, cleaning and assembly sequence. Share mating geometry, purchased hardware and the surfaces that affect motion, sealing or service access.
A component exposed to a fluid, cleaning agent, skin, tissue or another controlled environment needs a stated exposure and responsibility boundary. Provide the governing material specification and any biological, chemical or cleaning evaluation requirements instead of asking the supplier to infer them.
When a build needs material identity, feature reports, first-article scope, retained records or lot separation, define which parts and characteristics are covered. Evidence should trace to the released requirement and actual lot rather than a generic sample report.
Application risks
Most route risk comes from an unstated use condition or an evidence requirement added after manufacturing starts.
A component name does not reveal patient contact, duration, sterility, diagnostic function or risk classification. State the component boundary and the standards or controls that the buyer has determined apply; do not transfer device-level interpretation to an isolated part supplier.
A common alloy or polymer name does not establish compatibility with use, cleaning, sterilization or contact media. Control grade, condition, additives, colorants and permitted substitutions, and keep material selection responsibility explicit in the RFQ.
Machining cleanliness, particulate control, passivation, washing, packaging and sterilization are different operations with different acceptance methods. Define the requested incoming state and who owns any later validated process.
Industry experience, a website category or a network relationship is not evidence of a required quality system, registration or process approval. Name the exact supplier and document requirements so fit can be checked before a route is proposed.
Sourcing paths
Different component stages may use different processes while preserving the interfaces and records that matter.
CNC machining can support low-quantity housings, fixtures, manifolds and mechanisms when stock material, accessible geometry and revision flexibility fit. Review burr control, internal cleanliness, finishes, controlled features and any transition from prototype stock to a later process.
Molding and sheet fabrication can suit repeat housings, covers, brackets and fluid or cable-management features when draft, wall behavior, tooling, joints and cosmetic zones are intentional. Tool ownership, approved material and process validation remain project-defined.
A program may use appearance or fit models first, engineering samples second and a controlled production-intent route later. Freeze revision, material, critical interfaces and evidence at each release so a change in process is not mistaken for equivalent validation.
Program decision table
Typical published values for the materials and processes common in medical device component work. Component-level properties are not device-level compliance, and the project requirement is confirmed on the reviewed quote rather than from this table.
| Decision layer | Typical published value | Routing consequence |
|---|---|---|
| Common metals | 316L at 170 MPa / 25 ksi yield with a pitting resistance number of 24 to 26; 17-4 PH from 760 MPa / 110 ksi in Condition A; Ti Grade 5 at 880 MPa / 128 ksi | Grade and condition stated in full, not the family name |
| Common polymers | PEEK at about 100 MPa tensile with a heat-deflection figure near 152 °C at 1.8 MPa; acetal at 70 MPa; PEI at 105 MPa | Whether the polymer survives the sterilisation route |
| Steam sterilisation | Autoclave cycles run around 121 °C to 134 °C — PEEK and PEI tolerate it, acetal at roughly 90 °C continuous service does not | The sterilisation method stated before the material is fixed |
| Wetted surface finish | Commonly Ra 0.8 µm or better, and Ra 0.4 µm where cleaning validation requires it | Roughness as a stated requirement with a measurement method under ASME B46.1 |
| Electropolishing | Removes 10 to 40 µm and improves Ra by typically 25 to 50%, passivating in the same operation, commonly to ASTM B912 | Dimensional allowance designed in for the removal |
| Passivation | A separate specified operation, normally to ASTM A967; citric methods are preferred for martensitic and precipitation-hardening grades | The grade decides the method |
| Crevices and dead legs | Internal corners, blind holes and lap joints trap fluid and defeat cleaning regardless of surface finish | Geometry reviewed for cleanability, not just finish |
| Traceability | Material certificates to ASTM A276 or equivalent, lot boundaries, process handoffs and part identity as separate requirements | Where the lot boundary sits, and whether lots may be mixed |
| Part marking | Laser annealing leaves no material removal; engraving removes 5 to 50 µm and breaches the passive layer | Marking method, position and whether passivation follows |
| Prototype to production | A printed prototype at 30 to 70% interlayer strength does not represent a machined or moulded production part | Which conclusions the prototype supports |
| Cleanroom | A distinct and costly requirement separate from controlled cleaning and from a cleanliness test | Which is actually required |
| What a component supplier cannot provide | Device-level regulatory compliance, biocompatibility conclusions or sterilisation validation | Those remain with the device owner |
Industry RFQ inputs
Give reviewers enough context to qualify the part route without asking them to infer device-level requirements.
Complete packages move faster: revision-matched CAD, critical dimensions, quantity and material notes are enough to open engineering review across the network.
Get a QuoteSubmit the authoritative model, drawing, revision and matched assembly or mating context
State component function, program stage, use boundary and consequence of feature failure
Define material grade, condition, approved sources or substitutions and exposure conditions
Identify critical dimensions, datums, surface state, burr, cleanliness and packaging needs
List required supplier qualifications, material records, inspection reports and lot controls
Provide quantities, build cadence, change-control expectations and downstream validation ownership
Separate component manufacturing acceptance from device approval, sterilization and regulatory decisions
Questions before routing
These answers prepare the request; the reviewed quote controls project-specific commitments.
The supplier network includes manufacturers holding ISO 13485 and ISO 9001 certification, with cleanroom production and validated cleaning available where the component requires it. Component-level evidence routes with the parts: material certificates to specifications such as ASTM A276 or ASTM F136, dimensional reports on stated characteristics, surface roughness measurement under ASME B46.1, passivation records to ASTM A967, electropolishing to ASTM B912, and lot or serial traceability. What remains with the device owner is the device-level regulatory route — biocompatibility conclusions, sterilisation validation and the submission itself. Name the certification scope and evidence you need and it is confirmed on the reviewed quote.
The sterilisation method should be stated even when the operation itself is not in scope, because it constrains material and finish. Autoclave cycles run around 121 °C to 134 °C, which PEEK at a heat-deflection figure near 152 °C and PEI at about 200 °C tolerate but acetal at roughly 90 °C continuous service does not. Gamma and ethylene oxide have their own material effects. State the method, cycle count and any surface requirement.
Rarely without review, and the gap is usually mechanical rather than dimensional. A printed part carries interlayer strength at only 30 to 70% of its in-plane value and is slightly porous; a machined or moulded part is neither. Surface finish differs too: powder-bed parts come off at Ra 8 to 15 µm against Ra 0.8 µm or better on a machined wetted surface. State what the part must do, and the appropriate route follows.
Material certificates against a named specification such as ASTM A276, dimensional reports on stated characteristics at a stated revision, surface roughness measurement under ASME B46.1, passivation records to ASTM A967, electropolishing records to ASTM B912, heat-treatment records where the property is created after arrival, and traceability from lot to delivered part. Each is a defined deliverable with its own scope, confirmed on the reviewed quote.
Because cleanability is a surface and geometry property before it is a material one. 316L resists chlorides well at a pitting resistance number of 24 to 26, but a rough or crevice-rich surface holds residue that no grade prevents — internal corners, blind holes and lap joints defeat cleaning regardless of alloy. Wetted surfaces are commonly specified at Ra 0.8 µm or better, and Ra 0.4 µm with electropolishing where validation demands it. State both the finish and the geometry requirement.
Next step
Send the application context with the controlled part package. MakeNexa routes capable suppliers from a global network covering competitor-class process categories, then returns a prepared quote or focused clarification for your revision.
MAKENEXA